Marinus Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-BlackRock, Inc.(3.4%)
Marinus Pharmaceuticals | 4:持股变动声明-董事 Silverstein Christine Berni
Marinus Pharmaceuticals | 4:持股变动声明-董事 Austin Charles
Marinus Pharmaceuticals | 4:持股变动声明-高管 Shafer Christina
Marinus Pharmaceuticals | 4:持股变动声明-董事 Johnson Marvin
Marinus Pharmaceuticals | 4:持股变动声明-董事 Nochur Sara
Marinus Pharmaceuticals | 4:持股变动声明-董事 MAYLEBEN TIMOTHY M
Marinus Pharmaceuticals | 4:持股变动声明-董事 Noonberg Sarah B.
Marinus Pharmaceuticals | 4:持股变动声明-董事 Fischer Seth H. Z.
Marinus Pharmaceuticals | 4:持股变动声明-董事 Ezickson Elan
Marinus Pharmaceuticals | 4:持股变动声明-高管 Braunstein Scott
Marinus Pharmaceuticals | 4:持股变动声明-高管 Pfanstiel Steven
Marinus Pharmaceuticals | 4:持股变动声明-高管 Hulihan Joseph
Marinus Pharmaceuticals | 4:持股变动声明-高管 MANNING MARTHA E
Marinus Pharmaceuticals | SC 13G:超过5%持股股东披露文件-Citadel Securities LLC(0.4%),Citadel Securities Group LP(0.4%)等
Marinus Pharmaceuticals | SC 13G:超过5%持股股东披露文件-TANG CAPITAL PARTNERS, LP(8.2%),Tang Capital Management, LLC(8.2%)等
Marinus Pharmaceuticals | 4:持股变动声明-高管 Braunstein Scott
Marinus Pharmaceuticals | 4:持股变动声明-高管 MANNING MARTHA E
Marinus Pharmaceuticals | 4:持股变动声明-高管 Shafer Christina
Marinus Pharmaceuticals | 4:持股变动声明-高管 Hulihan Joseph
暂无数据